Many biopharmaceutical companies with one or a few ‘assets’ do not have the in-house resources or experience to fully evaluate the potential of business development targets. They miss out on the opportunity to generate and assess options to see the different or wider possibilities for the assets they are interested in.
In a ‘sellers market’ healthcare companies need to prove why and how they can be the development or commercialisation partner of choice. The Kasocio Business Development proposition is to provide additional support when time and internal resource is limited. Using our expertise we are able to help our clients to see additional hidden value in assets that perhaps the vendor/ partner has not seen.